Dr. Suheda Erener is currently investigating whether micro-RNAs – a family of single-stranded molecules which are key regulators of gene expression and beta cell function – can predict the development of T1D.
Upon a recent appointment with her endocrinologist, Meagan learned she would need to start with a new insulin pump that would give her the best control possible, but would also result on relying on a CGM — an expense she wasn’t prepared for, despite being a working professional with private insurance.
January 25, 2020 As Canada continues to break its silence on the discussion around mental illness, this #BellLetsTalk Day we thought it was important to shed light on the power […]
In a new funding opportunity led by the Canadian Institutes for Health Research (CIHR), JDRF will partner with the federal agency to fund several new team grants that aim to uncover new mechanisms that control the onset and progression of diabetes and its related complications.
National Diabetes Awareness Month (NDAM) has officially come to an end, and we cannot thank you enough for your overwhelming support and participation.
Here are some of the great initiatives you took part on that helped make this NDAM so special.
Beth Miller is a driven athlete with an indomitable spirit and a passion for life. At 16 years old, the Calgary resident has competed nationally in skiing and is currently a competitive rower who has represented her province twice at the National Rowing Championships – all while living with type 1 diabetes (T1D), an autoimmune disease that has challenged her daily since the young age of six.
JDRF has supported research in beta cell replacement for more than a decade, aiming to make a stem cell-based treatment for type 1 diabetes (T1D) a reality.
Geoff Beattie has been a devoted JDRF volunteer and active fundraiser since 2004 when his daughter was diagnosed with type 1 diabetes (T1D). Currently serving as cabinet co-chair for the In Our Lifetime Campaign for Central Canada, Geoff shares his story on how the chronic illness inspired his involvement with JDRF and changed his outlook on life.
The holidays are right around the corner, which means family gatherings and parties complete with great food, alcohol, and eating at random times. It is also a time when we are running around with last minute shopping, long car drives, and sleeping too little. Needless to say, managing blood glucose levels can be tricky.
Sernova Corp., a regenerative medicine company based in London, ON., has shown in its JDRF-funded clinical trial that its cell replacement therapy, Cell PouchTM, can restore insulin production among people living with T1D.
Type 1 diabetes became a part of Danny Miller’s family’s life just 18 months ago when his son, Cody, was diagnosed. #DearType1 has allowed him to share his story.
People living with diabetes are predisposed to several different complications given their fluctuating glucose levels, which can lead to stress on their organs. When it comes to cardiovascular problems, the extra risk conferred by having type 1 diabetes (T1D) may be greater in women than men.
